Background: Heart failure (HF) patients commonly experience obstructive sleep apnea
(OSA), which may worsen their condition. We reviewed a diverse range of studies to …

Purpose The purpose of this article is to review the recent literature on central apnea. Sleep
disordered breathing (SDB) is characterized by apneas (cessation in breathing), and …

Background Novel treatments targeting in baroreflex sensitivity (BRS) and chemoreflex
sensitivity (CRS) heart failure (HF) are grounded on small prognostic studies, partly …

Purpose Little is known about the mechanism underlying Sacubitril/Valsartan effects in
patients with heart failure (HFrEF). Aim of the study is to assess hemodynamic vs. non …

Background Heart failure with reduced ejection fraction (HFrEF) is a clinical condition
frequently diagnosed in clinical practice. In patients affected by HFrEF, sleep apnea (SA) …

Aims Sacubitril/valsartan has been demonstrated to have cardiovascular benefits in patients
with chronic heart failure (CHF). We aimed to conduct a meta-analysis of its effects on life …

Objective This study aimed to evaluate the effect of sacubitril-valsartan (SV) on central
apneas (CA) and obstructive apneas (OA) in patients with heart failure with reduced ejection …

In heart failure patients with reduced ejection fraction, Sacubitril/valsartan (S/V) increased
proBNP T71 glycosylation, which is regulated negatively by hypoxia via miR-30a in vitro …

Background Heart failure and sleep-disordered breathing have been increasingly
recognized as co-occurring conditions. Their bidirectional relationship warrants investigation …

Central sleep apnea (CSA) has always been a challenge to diagnose and treat. Especially
patients with fluid overload, such as patients with heart failure (HF) present with CSA [1]. In …